uniQure NV (FRA:UQ1) Days Sales Outstanding : 80.10 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is uniQure NV Days Sales Outstanding?

uniQure NV's average Accounts Receivable for the three months ended in Mar. 2024 was €6.85 Mil. uniQure NV's Revenue for the three months ended in Mar. 2024 was €7.81 Mil. Hence, uniQure NV's Days Sales Outstanding for the three months ended in Mar. 2024 was 80.10.

The historical rank and industry rank for uniQure NV's Days Sales Outstanding or its related term are showing as below:

FRA:UQ1' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.77 Med: 109.46 Max: 1227.6
Current: 860.13

During the past 13 years, uniQure NV's highest Days Sales Outstanding was 1227.60. The lowest was 22.77. And the median was 109.46.

FRA:UQ1's Days Sales Outstanding is ranked worse than
95.2% of 895 companies
in the Biotechnology industry
Industry Median: 72.67 vs FRA:UQ1: 860.13

uniQure NV's Days Sales Outstanding declined from Mar. 2023 (1,784.27) to Mar. 2024 (80.10).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

uniQure NV Days Sales Outstanding Historical Data

The historical data trend for uniQure NV's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

uniQure NV Days Sales Outstanding Chart

uniQure NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

29.44

37.24

22.61

269.89

1,262.33

uniQure NV Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															1,784.27	3,928.71	3,330.21	40.05	80.10

Competitive Comparison of uniQure NV's Days Sales Outstanding

For the Biotechnology subindustry, uniQure NV's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

uniQure NV's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, uniQure NV's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where uniQure NV's Days Sales Outstanding falls into.

uniQure NV Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

uniQure NV's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (96.643	+	3.845)	/	2 )	/	14.528	*	365
=	50.244					/	14.528	*	365
=	1,262.33

uniQure NV's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (3.845	+	9.86)	/	2 )	/	7.806	*	365 / 4
=	6.8525					/	7.806	*	365 / 4
=	80.10

uniQure NV (FRA:UQ1) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

uniQure NV Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of uniQure NV's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

uniQure NV (FRA:UQ1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » uniQure NV (FRA:UQ1) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

QURE:USA

Address

Paasheuvelweg 25, Amsterdam, NH, NLD, 1105 BP

Website

https://www.uniqure.com

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

uniQure NV (FRA:UQ1) Headlines

No Headlines